BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cañueto J, Burguillo J, Moyano-Bueno D, Viñolas-Cuadros A, Conde-Ferreirós A, Corchete-Sánchez LA, Pérez-Losada J, Román-Curto C. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice. J Am Acad Dermatol 2019;80:106-113.e2. [PMID: 30003984 DOI: 10.1016/j.jaad.2018.06.060] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Conforti C, Paolini F, Venuti A, Dianzani C, Zalaudek I. Comment on `The detection rate of human papillomavirus in well‐differentiated squamous cell carcinoma and keratoacanthoma: is there new evidence for a viral pathogenesis of keratoacanthoma?' ‐ reply from authors. Br J Dermatol 2019;181:1345-6. [DOI: 10.1111/bjd.18385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Ibrahim SF, Kasprzak JM, Hall MA, Fitzgerald AL, Siegel JJ, Kurley SJ, Covington KR, Goldberg MS, Farberg AS, Trotter SC, Reed K, Brodland DG, Koyfman SA, Somani AK, Arron ST, Wysong A. Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile test. Future Oncol 2021. [PMID: 34821148 DOI: 10.2217/fon-2021-1277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mousa AK, Elshenawy AA, Maklad SM, Bebars SMM, Burezq HA, Sayed SE. Post-burn scar malignancy: 5-year management review and experience. Int Wound J 2021. [PMID: 34535972 DOI: 10.1111/iwj.13690] [Reference Citation Analysis]
4 Ebrahimi A, Gupta R, Luk P, Low TH, McDowell L, Magarey MJR, Smith PN, Perriman DM, Schulte KM, Veness M, Porceddu SV, Clark JR. Number of nodal metastases and the American Joint Committee on cancer staging of head and neck cutaneous squamous cell carcinoma: A multicenter study. Oral Oncol 2020;111:104855. [PMID: 32835932 DOI: 10.1016/j.oraloncology.2020.104855] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Patel VA, McCullum C, Sparks AD, Schmults CD, Arron ST, Jambusaria-Pahlajani A. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study. Cancer Med 2021. [PMID: 34796670 DOI: 10.1002/cam4.4426] [Reference Citation Analysis]
6 Conforti C, Giuffrida R, Pizzichetta M, Di Meo N, Magaton‐rizzi G, Zalaudek I. Integrating the concept of field cancerization in the classification and risk assessment of cutaneous squamous cell carcinoma: proposal for a new classification and terminology of keratinocyte skin cancer. J Eur Acad Dermatol Venereol 2019;33. [DOI: 10.1111/jdv.15624] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
7 Conde-ferreirós A, Corchete LA, Puebla-tornero L, Corchado-cobos R, García-sancha N, Román-curto C, Cañueto J. Definition of prognostic subgroups in the T3 stage of the eighth edition of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Tentative T3 stage subclassification. Journal of the American Academy of Dermatology 2020. [DOI: 10.1016/j.jaad.2020.03.088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Upton M, Kita A, Scapa J, St John M. Prognostic Value of Tumor Staging: Predicting Nodal Metastases in Cutaneous Squamous Cell Carcinoma. Laryngoscope 2021;131:E170-5. [PMID: 32212346 DOI: 10.1002/lary.28633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Cañueto J. Implementation of staging systems in clinical practice for cutaneous squamous cell carcinoma. Ann Transl Med 2019;7:S51. [PMID: 31032330 DOI: 10.21037/atm.2019.03.13] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Cañueto J, Tejera-Vaquerizo A, Redondo P, Botella-Estrada R, Puig S, Sanmartin O. A review of terms used to define cutaneous squamous cell carcinoma with a poor prognosis. Actas Dermosifiliogr (Engl Ed) 2020;111:281-90. [PMID: 32359704 DOI: 10.1016/j.ad.2019.06.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Liu X, Liu F, Yu H, Zhang Q, Liu F. Development and Validation of a Prediction Model for Predicting the Prognosis of Postoperative Patients with Hepatocellular Carcinoma. IJGM 2022;Volume 15:3625-37. [DOI: 10.2147/ijgm.s351265] [Reference Citation Analysis]
12 Dessinioti C, Pitoulias M, Stratigos AJ. Epidemiology of advanced cutaneous squamous cell carcinoma. J Eur Acad Dermatol Venereol 2021. [PMID: 34592000 DOI: 10.1111/jdv.17709] [Reference Citation Analysis]
13 Watts F, Palme CE, Porceddu S, Sundaresan P, Clark JR, Gupta R. Clinician perspectives on the factors influencing prognostic stratification by the American Joint Commission on Cancer Head and Neck Cutaneous Squamous Cell Carcinoma Staging. Surgery 2021:S0039-6060(21)00344-5. [PMID: 34130810 DOI: 10.1016/j.surg.2021.04.019] [Reference Citation Analysis]
14 Yan F, Knochelmann HM, Morgan PF, Kaczmar JM, Neskey DM, Graboyes EM, Nguyen SA, Ogretmen B, Sharma AK, Day TA. The Evolution of Care of Cancers of the Head and Neck Region: State of the Science in 2020. Cancers (Basel) 2020;12:E1543. [PMID: 32545409 DOI: 10.3390/cancers12061543] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
15 Arron ST, Wysong A, Hall MA, Bailey CN, Covington KR, Kurley SJ, Goldberg MS, Kasprzak JM, Somani A, Ibrahim SF, Brodland DG, Cleaver NJ, Maher IA, Xia Y, Koyfman SA, Newman JG. Gene expression profiling for metastatic risk in head and neck cutaneous squamous cell carcinoma. Laryngoscope Investig Oto. [DOI: 10.1002/lio2.724] [Reference Citation Analysis]
16 Bowe CM, Houlton S, Walsh S. Comparison of the eighth edition of the TNM and Brigham Women's Hospital staging systems for cutaneous squamous cell carcinoma of the head and neck: a six-year review. Br J Oral Maxillofac Surg 2020;58:1158-63. [PMID: 33071049 DOI: 10.1016/j.bjoms.2020.08.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Farberg AS, Fitzgerald AL, Ibrahim SF, Tolkachjov SN, Soleymani T, Douglas LM, Kurley SJ, Arron ST. Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review. Dermatol Ther (Heidelb) 2022. [PMID: 34994967 DOI: 10.1007/s13555-021-00673-y] [Reference Citation Analysis]
18 Bibee K, Swartz A, Sridharan S, Kurten CHL, Wessel CB, Skinner H, Zandberg DP. Cutaneous squamous cell carcinoma in the organ transplant recipient. Oral Oncol 2020;103:104562. [PMID: 32065978 DOI: 10.1016/j.oraloncology.2019.104562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Knackstedt TJ, Knackstedt RW, Djohan M, Djohan R, Gastman BR, Crowe DR. New Developments in the Management of Cutaneous Squamous Cell Carcinoma. Plast Reconstr Surg 2021;147:492-504. [PMID: 33620947 DOI: 10.1097/PRS.0000000000007678] [Reference Citation Analysis]
20 Puebla-Tornero L, Corchete-Sánchez LA, Conde-Ferreirós A, García-Sancha N, Corchado-Cobos R, Román-Curto C, Cañueto J. Performance of Salamanca refinement of the T3-AJCC8 versus the Brigham and Women's Hospital and Tübingen alternative staging systems for high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol 2021;84:938-45. [PMID: 33333151 DOI: 10.1016/j.jaad.2020.12.020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Ebrahimi A, Luk PP, Low H, McDowell L, Magarey MJR, Smith PN, Perriman DM, Veness M, Gupta R, Clark JR. A critical analysis of the 8th edition TNM staging for head and neck cutaneous squamous cell carcinoma with lymph node metastases and comparison to N1S3 stage and ITEM risk score: A multicenter study. J Surg Oncol 2021;123:1531-9. [PMID: 33721339 DOI: 10.1002/jso.26410] [Reference Citation Analysis]
22 Pacella G, Capell BC. Epigenetic and metabolic interplay in cutaneous squamous cell carcinoma. Exp Dermatol 2021;30:1115-25. [PMID: 33844325 DOI: 10.1111/exd.14354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Dominguez-Cherit J. Subungual Invasive Squamous Cell Carcinoma with Doubtful Underlying Bone Invasion: A Treatment Proposal. Skin Appendage Disord 2021;7:108-11. [PMID: 33796555 DOI: 10.1159/000511740] [Reference Citation Analysis]
24 Litchman GH, Fitzgerald AL, Kurley SJ, Cook RW, Rigel DS. Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma. Curr Med Res Opin 2020;36:1295-300. [PMID: 32372702 DOI: 10.1080/03007995.2020.1763283] [Reference Citation Analysis]
25 Ebrahimi A, Luk PP, Low H, McDowell L, Magarey MJR, Smith PN, Perriman DM, Shadbolt B, Veness M, Gupta R, Clark JR. The American Joint Committee on Cancer staging for metastatic head and neck cutaneous squamous cell carcinoma: A multi-institutional study of within-stage heterogeneity and impact on prognostic performance. Head Neck 2020;42:3235-42. [PMID: 32840938 DOI: 10.1002/hed.26369] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Leus AJG, van Dijk BAC, Postmus D, Plaat BEC, Halmos GB, Diercks GFH, Rácz E, van Kester MS. "Prediction of poor outcome for cutaneous squamous cell carcinoma of the head and neck comparing classification systems: a competing risk analysis". J Invest Dermatol 2022:S0022-202X(22)00199-3. [PMID: 35304251 DOI: 10.1016/j.jid.2022.02.015] [Reference Citation Analysis]
27 Tejera-Vaquerizo A, Cañueto J, Llombart B, Martorell-Calatayud A, Sanmartín O. Predictive Value of Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma Based on the AJCC-8 and Brigham and Women's Hospital Staging Criteria. Dermatol Surg 2020;46:857-62. [PMID: 31567487 DOI: 10.1097/DSS.0000000000002170] [Reference Citation Analysis]
28 Johnson TM, Smith NR. Mohs Surgery versus Standard Local Excision for Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma Skin Cancer. Facial Plast Surg 2020;36:133-40. [PMID: 32413920 DOI: 10.1055/s-0040-1709142] [Reference Citation Analysis]